ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Direxion Daily Biotech Top 5 Bull 2X ETF
38.36
-0.5386
-1.38%
盤後：
38.53
0.1700
+0.44%
16:10 EDT
成交量：
7,280
成交額：
28.42萬
市值：
287.70萬
市盈率：
- -
高：
39.06
開：
39.06
低：
38.36
收：
38.90
52周最高：
45.88
52周最低：
25.71
股本：
7.50萬
流通股本：
7.50萬
量比：
0.49
換手率：
9.71%
股息：
0.62
股息率：
1.62%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞
公告
BMO下調安進及BioNTech評級至「與大市同步」
格隆汇
·
09/08
美股盤前｜英特爾、甲骨文升逾4%；諾華重挫12%，IONIS下跌10%；阿斯麥新一代EUV光刻機獲台積電和三星使用承諾
老虎资讯综合
·
09/08
諾華試驗受挫且BMO下調評級，安進股價下跌
路透中文
·
09/08
盤前異動：安進、耐克、Bloom Energy 等個股受關注
投资观察
·
09/08
美股異動｜安進盤前跌5.4%，諾華同靶點藥物III期臨床失敗，Lp(a)賽道遭重創
中金财经
·
09/08
安進股價盤前下跌5.4%；競爭對手諾華的膽固醇藥物後期臨床試驗失敗。
智通财经
·
09/08
富國銀行上調安進目標價至435美元
格隆汇
·
09/08
諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影
路透中文
·
09/07
一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」
智通财经
·
09/07
摩根大通投行聯席負責人：併購交易業務有望迎來創紀錄年份。
智通财经
·
09/03
安進（AMGN）罕見病藥物Tavneos將於27年3月1日被徹底撤銷英國上市許可
金吾财讯
·
09/02
高盛9月「確信名單」更新：美股納入福泰製藥(VRTX.US) 歐股力推萊茵、Adyen和塔蘭克斯
智通财经
·
09/02
高盛9月「確信名單」更新：美股納入福泰製藥 歐股力推萊茵、Adyen和塔蘭克斯
智通财经
·
09/02
英國監管機構因數據不可靠，暫停安進公司Tavneos用於新患者
路透中文
·
09/01
英國藥品與健康產品管理局：通知上市許可持有方，自9月1日起暫停新患者使用、供應及銷售Avacopan Vifor
美股速递
·
09/01
特朗普政府將宣佈藥品定價協議
路透中文
·
09/01
機構：爭奪天然氣資產推高併購交易規模創2013年以來新高
智通财经
·
08/31
安進（AMGN）降脂藥Repatha新臨床數據：可降低未發生心梗或中風高危患者20%死亡風險
金吾财讯
·
08/31
南京諾令生物科技股份有限公司向港交所提交上市申請書，獨家保薦人為建銀國際。
智通财经
·
08/28
據港交所文件，維眸生物科技股份有限公司-B向港交所提交上市申請書。
智通财经
·
08/28
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/TBXU/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":38.3601,"timestamp":1789156800000,"preClose":38.8987,"halted":0,"volume":7280,"hourTrading":{"tag":"盘后","latestPrice":38.5301,"preClose":38.3601,"latestTime":"16:10 EDT","volume":6,"amount":230.1604,"timestamp":1789157404900,"change":0.17,"changeRate":0.004432,"amplitude":0},"delay":0,"changeRate":-0.01384622108193835,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"未開盤","change":-0.5386,"latestTime":"09-11 16:00:00 EDT","open":39.06,"high":39.06,"low":38.3601,"amount":284204,"amplitude":0.017993,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":38.8987,"sharesOutstanding":100001,"nav":38.336,"aum":2875239.83,"dividendRate":0.01621,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":38.5301,"preClose":38.3601,"latestTime":"16:10 EDT","volume":6,"amount":230.1604,"timestamp":1789157404900,"change":0.17,"changeRate":0.004432,"amplitude":0},"volumeRatio":0.4910292679310407},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4910292679310407,"shares":75001,"dividePrice":0.6218,"high":39.06,"amplitude":0.017993,"preClose":38.8987,"low":38.3601,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":38.3601,"eps":0,"divideRate":0.01621,"volume":7280,"delay":0,"ttmEps":0,"open":39.06,"prevYearClose":31.065,"prevWeekClose":44.3833,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":45.76,"twentyDayClose":38.3309,"sixtyDayClose":29.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665387373","title":"BMO下調安進及BioNTech評級至「與大市同步」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665387373","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665387373?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:59","pubTimestamp":1788872377,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE0002141913.USD","LU2112291526.USD","BK4585","BK4534","SG9999001440.SGD","BIB","LU0109394709.USD","LU0320765992.SGD","BK4533","BBH","LU2089984988.USD","LU0122379950.USD","LU2242652126.USD","LU2468319806.SGD","IE00B2B36J28.USD","IBBQ","IBB","LU1983299246.USD","IE0009355771.USD","BK4581","AMGN","PJP","LU0289739699.SGD","IE00BFTCPJ56.SGD","PBE","LU0868494617.USD","LU1061106388.HKD","LU2242646821.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4599","LU1023059063.AUD","BK4566","TBXU","LU0889565916.HKD","LU1057294990.SGD","IE00B4R5TH58.HKD","BK4588","LU0058720904.USD","BK4139","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103332998","title":"美股盤前｜英特爾、甲骨文升逾4%；諾華重挫12%，IONIS下跌10%；阿斯麥新一代EUV光刻機獲台積電和三星使用承諾","url":"https://stock-news.laohu8.com/highlight/detail?id=1103332998","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103332998?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:01","pubTimestamp":1788868860,"startTime":"0","endTime":"0","summary":"9月8日美元指数上升0.0364%，报98.96。03 要闻1. 三大芯片厂全面采购ASML最先进High NA EUV光刻机以扩产高端制程。ASML确认三星、台积电与英特尔已承诺在2028–2030年起量产使用High NA设备，并与ASML签订光罩尺寸升级合作协议，助力降低AI芯片制造成本。","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","IE00B7SZL793.SGD","LU0433182093.SGD","LU1582987597.SGD","LU2326559502.SGD","ORCX","LU2272731865.HKD","BK4505","BBH","BK4157","WEEI","LU2322448791.USD","LU2491050071.SGD","LU0170899867.USD","LU0149725797.USD","LU1582986359.USD","CHPX","LU1917777945.USD","LU2473716301.USD","BK7104","SG9999014567.USD","IE00BMPRXQ63.HKD","LU1934455863.HKD","INTC","LU1734074674.USD","UDOW","IGV","LU1093756168.USD","IE0009355771.USD","IE00B2Q91V27.USD","LU0541502299.USD","DIA","LU1430594728.SGD","LU2298321311.HKD","TEK","HK0000304797.USD","AVEM","LU0957808578.USD","LU0082616367.USD","LU0175139822.USD","OGIG","TEXU","LU1066051498.USD","LU0203347892.USD","THNR","LU0130103400.USD","TINS","LU2324357040.USD","MEDX","ASMH","IE00B19Z3B42.SGD","SG9999002232.USD","IE00BD6J9T35.USD","LU0256863811.USD","OILT","CNEQ","LU1804176565.USD","BK4527","LU0345769128.USD","LU0965509283.SGD","LU0198837287.USD","LU1267930490.SGD","OZEM","LU0077335932.USD","BK4554","PXE","LU2249611893.SGD","SG9999014542.SGD","BK4138","BK4575","LU0310799852.SGD","LU2242652126.USD","ASIA","LU0878005551.USD","LU1037948541.HKD","LU0143551892.USD","LU1839511570.USD","LU2125154778.USD","LU0266512473.USD","BK4548","LU1057294990.SGD","LU2458330169.SGD","LU2102340556.USD","LU0056508442.USD","LU0052756011.USD","LU0320765489.SGD","FFGX","LU0251131958.USD","LU0251132253.USD","LU0878004406.USD","LU2506952097.USD","LU0300736492.USD","IE00BYQQ9H92.USD","LU2764263039.SGD","LU2430703178.SGD","LU1815333072.USD","LU2506951875.HKD","LU1582986433.USD","TBXU","LU1868838027.USD","LU1235294995.USD","LU0154245756.USD","LU2458330243.SGD","QTUP","EMM","LU1366192091.USD","CHAT","LU2250418816.HKD","LU0985489474.SGD","IGE","DXD","LU1035773651.USD","LU0029874061.USD","TRUN","LU1674673428.USD","LU0300736062.USD","LU1267930227.SGD","IE00B5949003.HKD","BK4591","LU2746668461.USD","LU1023057109.AUD","LU0553294199.USD","LU0823039010.USD","LU0256331488.USD","LU0058720904.USD","LU2237443382.USD","BK4599","IE0004091025.USD","LU2357125470.USD","NVS","XNTK","BK4550","DBEU","LU2764262908.HKD","LU0359202008.SGD","LU0109392836.USD","PXI","BK4578","LU1162221912.USD","IE0000B7K699.USD","LU2265009873.SGD","IE00BLSP4239.USD","LU2041044095.USD","LU2237443978.SGD","LU2237957902.USD","LU0912757837.SGD","SGXZ99366536.SGD","BK4535","LU0642271901.SGD","LU2322448957.HKD","LU0211327993.USD","LU1316542783.SGD","IE00B775SV38.USD","BK4512","LU1201861165.SGD","LU2106854487.HKD","GXPE","BK4170","LU0823038988.USD","LU0353189763.USD","IE00B66KJ199.SGD","IE00BN8TJ469.HKD","LU0320765992.SGD","LU2023251221.USD","LU2211814178.USD",".DJI","LU0488056044.USD","LU2543165471.USD","LU1291159041.SGD","IE0034235303.USD","LU1691799644.USD","IE0002141913.USD","LU0208291251.USD","LU1929549753.HKD","AIS","LU2360106780.USD","LU1894683264.USD","FTXN","LU1712237335.SGD","SG9999011175.SGD","LU0345781412.USD","WQTM","LU0238689110.USD","LU0130102774.USD","LU0310800965.SGD","LU1988902786.USD","LU2750360641.GBP","LU0444971666.USD","IE00BKVL7J92.USD","LU0466842654.USD","LU0094547139.USD","LU0431992006.USD","IYE","CTEX","LU1571399168.USD","CQTM","LU1435385759.SGD","IE00BZ1G4Q59.USD","LU1935043536.SGD","IE00B7SZLL34.SGD","LU0980610538.SGD","SGXZ81514606.USD","LU0162691827.USD","LU0792757196.USD","LU0878866978.SGD","SGXZ51526630.SGD","LU1585245621.USD","LU0048584097.USD","LU0868494617.USD","LU2054465674.USD","LU0859254822.USD","LU0368265418.SGD","LU0154236417.USD","DOG","IE00B4R5TH58.HKD","LU1883866441.USD","BK4559","LU0545039389.USD","LU0882574055.USD","LU0321505868.SGD","IE00B3M56506.USD","IE00BBT3K403.USD","LU0266013472.USD","ERX","IE00BFXG1179.USD","LU0823417737.USD","LU0278409577.USD","LU0823434583.USD","LU2360107168.USD","LU0345770308.USD","TNGY","LU2506952170.USD","LU2237957811.SGD","BK4201","FOTO","LU0661504455.SGD","LU0359201612.USD","LU0130517989.USD","LU1732799900.SGD","LU0788109394.HKD","BK4007","IE00BQXX3D17.EUR","BK4141","LU0084288322.USD","SG9999002521.SGD","BK4529","BAI","ORCL","LU2954938101.SGD","DBEF","LU2148611432.USD","SG9999001176.USD","IE00BLSP4452.SGD","BK4534","AVXC","ORCU","LU0274383776.USD","LU0823417653.USD","LU2357305700.SGD","LU0965509010.AUD","DDM","IBB","LU0889566641.SGD","LU1823568750.SGD","LU0211326839.USD","LU2236285917.USD","DIG","LU0211331839.USD","IE00BKPKM429.USD","LU0314106906.USD","DRIV","LU0157215616.USD","LU0225283273.USD","BK4148","LU0211326755.USD","LU0572939691.SGD","CHPS","LU0957791311.USD","LU1868837565.USD","BK4608","LU1791710582.SGD","LU2491050154.USD","BK5113","LU1989764664.SGD","LU0122379950.USD","LU0124676726.USD","LU2471134879.HKD","INT","IE00BFTCPJ56.SGD","LU2089284900.SGD","IE000SO60NU8.SGD","LU0417517546.SGD","LU0143863198.USD","LU2746668974.SGD","BK4082","LU2764263203.CNY","LU1868837722.USD","ILOW","IEO","IE00B3S45H60.SGD","SG9999003800.SGD","QQQA","LU1852331112.SGD","SG9999004220.SGD","SG9999013999.USD","LU2237443622.USD","CRAK","BK4503","LU0942090050.USD","LU0070217475.USD","LU2860962120.EUR","BK4538","LU2087625088.SGD","LU0528227936.USD","ORCZ","LU1720051017.SGD","IE00BWXC8680.SGD","LU0053666078.USD","LU0122376428.USD","LU0264606111.USD","SG9999001440.SGD","LU0683600562.USD","LU1074936037.SGD","SG9999001424.SGD","LU0823434740.USD","LEGR","LU1718418525.SGD","LU2294711713.HKD","LU0630314457.HKD","IXC","LU0823414551.USD","BK4147","IE0031619046.USD","LU2602419157.SGD","LU1732800096.USD","LU2125154935.USD","LU0719512351.SGD","IFLR","LU1003077747.HKD","LU1992135399.USD","BK4581","SDOW","LU0823421416.USD","LU0689626769.HKD","LU0109394709.USD","LU0654597011.USD","BGIA","IE00B19Z4B17.USD","BK4097","IE00B2B36J28.USD","LU2462591277.SGD","LU2487616109.SGD","LU0432979614.USD","BK4570","LU0070302665.USD","LU2063271972.USD","LU0612318971.USD","LU1989764748.USD","BK4612","FENY","ADVE","LU0742534661.SGD","CWI","LU2505996509.AUD","LU2129689431.USD","EFA","LU0359201885.HKD","LU1803068979.SGD","LU2663582299.SGD","SG9999002224.SGD","IE0009356076.USD","LU2133065610.SGD","KNOW","IE00BZ199S13.USD","LU0158827781.USD","LU2247934214.USD","LU1791710400.SGD","ESIM","LU2087621335.USD","LU1506573853.SGD","LU0081259029.USD","LU1366333091.USD","HK0000304805.HKD","BIB","LU2357627491.SGD","INTW","ORCS","LU0384037296.USD","GSID","PQNT","IE00BMPRXR70.SGD","LU1046421795.USD","IE00B3CCJ963.GBP","LU1989772840.SGD","LU1429558221.USD","LU1037948897.HKD","LU0950375773.USD","LU2506951792.HKD","PPH","IE00BJT1NW94.SGD","LU0323591593.USD","LU2471134796.USD","LU0648000940.SGD","LU2112291526.USD","PBE","LU0011850046.USD","03165","LU2244417387.USD","LU2242646821.SGD","ORAC","LU0210528500.USD","LU2999663052.SGD","LU0128525689.USD","LU1093756325.SGD","LU1894683348.USD","UMMA","LU2505996681.GBP","LU0289960550.SGD","BK4579","BK4515","LU1061106388.HKD","BK4213","LU0476273544.USD","03145","LU1674673691.USD","LU1935042215.USD","LU1508157978.USD","LU0787776722.HKD","LU2272731600.USD","CGIC","LU0154245673.USD","LU1023059063.AUD","SG9999000418.SGD","SG9999001176.SGD","LU2347655156.SGD","IE0004086264.USD","AIQ","LU0889565833.HKD","LU1153585028.USD","BK4585","FCG","LU0345774391.USD","BLOX","TTEQ","LU1989772923.USD","LU1935043023.USD","LU1150488218.USD","IE00B5TLWC47.USD","LU0823421333.USD","IE00BKDWB100.SGD","LU0061474960.USD","LU0823414478.USD","INYY","LINT","LU2092937221.SGD","LU2360032135.SGD","LU0048573561.USD","LU1935042488.USD","LU0738911758.USD","LU2129689605.HKD","LU1211504680.USD","LU0128526141.USD","LU1489326972.SGD","LU2491049909.HKD","IE00BFXG0V08.USD","LU2242649171.HKD","LU2023250504.SGD","DRLL","LU2430703095.HKD","LU2211815571.USD","IE00BQXX3F31.USD","LU2471134523.USD","IE00BSNM7G36.USD","LU0210536198.USD","LU1778281490.HKD","LU2108987350.USD","LU2471134952.CNY","LU1048588211.SGD","IE00B1BXHZ80.USD","IE00B1XK9C88.USD","BK7095","LU1720051108.HKD","LU2111349929.HKD","SPWO","HBMX","IE00BHPRN162.USD","LU2750360997.AUD","TDIV","LU0158827948.USD","LU0795875086.SGD","LU0234572021.USD","CORO","LU0289739699.SGD","LU0072462343.USD","BK4566","LU1861215975.USD","LU2430703251.USD","IE0002270589.USD","LU1934455277.USD","WUGI","LU0572940350.SGD","IEFA","LUMA","LU2089985449.USD","BK4516","LU0456854461.SGD","LU1066053197.SGD","LU0949170772.SGD","LU1323610961.USD","LU0143863784.USD","LU2468319806.SGD","PJP","LU1934455194.USD","LU0348723411.USD","LU2264538146.SGD","LU0072461881.USD","AVSE","BK4588","LU0823416689.USD","BK4528","LU0889565916.HKD","FTXL","CNAV","LU2129689514.USD","LU2290526834.HKD","BK4023","LU0234570918.USD","MEMX","LU0068578508.USD","LU0868494708.USD","LU1642822529.SGD","LU1064131342.USD","SG9999015341.SGD","IE0004445239.USD","LU1282649067.USD","BK4526","LU1983299246.USD","CGNG","CGDG","LU1861220033.SGD","BK4602","LU0976567544.SGD","LU2089283258.USD","IE000F7OJYX1.SGD","LU2028103732.USD","RSPG","LU1623119135.USD","LU2896262040.SGD","IE000MB6IJN5.SGD","BK4139","LU0345774631.USD","LU2362541513.USD","BK4504","SGXZ57979304.SGD","EMC","LU1974910355.USD","LU0882747503.HKD","LU1582987324.SGD","LU2089984988.USD","LU0477156953.USD","BK4533","LU0353189680.USD","LU0187121727.USD","LU1201861249.SGD","SPY","IE000WAW04H5.SGD","LU0345769631.USD","LU0861579265.USD","SPRX","LU0648001328.SGD","BK4532","LU0868486357.SGD","SOXX","LU1430597077.USD","IE00BQXX3C00.GBP","LU0097036916.USD","LU0345780950.USD","LU0203345920.USD","LU2272731782.SGD","LU2592432038.USD","LU1815336760.USD","SG9999014575.USD","LU2462611646.USD","FENI","LU0211328371.USD","SG9999015358.SGD","LU0541501648.USD","BK4592","VDE","EPAI","LU2271345857.HKD","LU0444973449.USD","LU2362541273.HKD","LU0321505439.SGD","BK4605","LU1548497426.USD","LU2362540622.SGD","SPTE","LU0965509101.SGD","LU0345770993.USD","LU1150488135.SGD","LU1935042991.SGD","SG9999014559.SGD","LU0267386448.USD","LU1989771016.USD","IE00BGHQF524.EUR","IE00BMPRXN33.USD","LU0496365809.HKD","LU0316494557.USD","LU2506951958.HKD","IBBQ","XLE","LU0795875169.SGD","LU1069347547.HKD","LU1282649810.SGD","LU1267930813.SGD","LU0098860793.USD","BK4121","LU1992135472.HKD","SMH","LU0114720955.EUR","GNOM","IE000BZT7R73.USD","LU0320765646.SGD","LU0612318385.USD","IE00B19Z3581.USD","IE000M9KFDE8.USD","LU0965508806.USD","LU2498475776.HKD","LU0251142724.SGD","CGGO","LU0138981039.USD","FDTX","EGGY","HYDR","LU2931357623.SGD","IE00BJJMRZ35.SGD","GNMX","LU2360108059.USD","LU0266512127.USD","LU2237443549.SGD","LU2720916845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665215326","title":"諾華試驗受挫且BMO下調評級，安進股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2665215326","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665215326?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:27","pubTimestamp":1788859661,"startTime":"0","endTime":"0","summary":"BUZZ-诺华试验受挫且BMO下调评级，安进股价下跌9月8日-** 安进公司（AMGN.O）股价盘前下跌4.8%，至416美元** 诺华公司（NOVN.S）的降胆固醇药物在一项备受关注的研究中未能达标，这引发了市场对安进公司（Amgen）实验性降胆固醇药物olpasiran的担忧 (link)** 摩根大通分析师表示，诺华的pelacarsen研究结果降低了市场对安进olpasiran的预期，而该","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4500MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE0002141913.USD","LU0889565916.HKD","TBXU","LU1061106388.HKD","PBE","IE00B4R5TH58.HKD","IBB","IE00B2B36J28.USD","LU1023059063.AUD","AMGN","LU2242646821.SGD","SG9999001440.SGD","BK4581","LU0058720904.USD","PJP","LU1057294990.SGD","LU1571399168.USD","BK4585","BK4566","LU2089984988.USD","BK4534","LU2242652126.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4139","IE00BJJMRZ35.SGD","BK4599","LU0868494617.USD","LU1983299246.USD","LU0122379950.USD","LU2112291526.USD","BBH","BK4533","IE0009355771.USD","BK4588","BIB","IBBQ","LU0289739699.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176595225","title":"盤前異動：安進、耐克、Bloom Energy 等個股受關注","url":"https://stock-news.laohu8.com/highlight/detail?id=1176595225","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176595225?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:10","pubTimestamp":1788858632,"startTime":"0","endTime":"0","summary":"安进：这家生物科技巨头、道琼斯指数的重要权重股，其盘前股价重挫逾5%。此前，瑞士制药商诺华宣称，其一款实验性药物在晚期临床试验中未能有效降低心血管风险。安进与礼来目前正在各自研发竞品疗法以应对挑战。消息传出后，诺华在欧股市场大跌10%，礼来股价亦小幅走低。Bloom Energy：这家燃料电池制造商可谓利好连连。受此提振，其盘前股价上扬4%。游戏驿站定于今日美股收盘后发布财报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYY","BK4146","IE0009354923.USD","LU0052756011.USD","MSST","BK4566","IE00BJJMRZ35.SGD","BK4577","BPAY","BBH","LU2089984988.USD","LU2357125470.USD","LU0823414478.USD","ROBN","COIA","VCLN","BK4588","BK4007","MSTY.UK","LU0128525689.USD","AMGN","SG9999001440.SGD","HOOZ","LU0476273544.USD","LU2264538146.SGD","CONI","LU2242646821.SGD","07399","LU1861220207.SGD","LU2242652126.USD","CONY","PJP","LU0823414551.USD","BK4561","LU2249611893.SGD","HOII","3SMI.UK","BK4112","LU2098885051.SGD","LU0823411888.USD","IMST","LU1983299246.USD","CONL","ZAP","07311","COIG","HOOI","MSDD","MSTZ","BIB","BK4595","LU1267930573.SGD","HOOW","BK4599","MSTY","LU0211331839.USD","BK4534","BK4539","LU0708994859.HKD","IE00B4R5TH58.HKD","BK4541","APED","COII","IE00BFTCPJ56.SGD","DAPP","COIO","TBXU","HOOC","LU0889566641.SGD","07799","GME","LU0310800379.SGD","CTEC","LU1861558580.USD","BKCH","09399","IBB","SMI3.UK","LU0320765992.SGD","CRPT","FRNW","LU0444973449.USD","LU0889565916.HKD","WNTR","BK4023","BEG","BK4127","LU0208291251.USD","LU1064131342.USD","LU1988902786.USD","LU0070302665.USD","MSOO","HOYY","LU0058720904.USD","ICLN","07711","LU2543165471.USD","LU0444971666.USD","FINX","LU1815336760.USD","BK4516","VTWG","BK4554","COIX","MST","COIW","GMEY","04332","STYL","ICOI","LU0029864427.USD","BLCK","BK4578","IAI","LU0122379950.USD","09311","LU1057294990.SGD","LU0310800965.SGD","MSTW","LU0957808578.USD","MSTP","IE00BYQQ9H92.USD","IBLC","WATS","CNRG","IE00B2B36J28.USD","IE0002141913.USD","BK4600","MSTR","BK4581","BK4551","EGGY","BK4533","LU2294711713.HKD","HOOD","IBBQ","MEDX","BK4076","HODU","PPH","LU1303367103.USD","LU2360107671.USD","BK4547","GMEU","LU1023059063.AUD","MSTU","IGME","BEZ","IE0009355771.USD","IBAT","LU0289739699.SGD","LU0792757196.USD","SIMS","SMOG","BEC","LMI3.UK","GMEC","HOOG","3LMI.UK","MSII","PBE","BK4182","OWNB","LU0786609619.USD","BE","LU2506951792.HKD","COIN","NVS","MSTK","LU2468319806.SGD","FIAT","LU0320765489.SGD","BK4558","BK4139","LU0109394709.USD","09711","LU2112291526.USD","LU1861559042.SGD","BEX","IE00BFXG0V08.USD","09799","BITQ","BK4535","HOOY","LU1642822529.SGD","NKE","BK4585","BK4596","LU1061106388.HKD","UPGR","LU1861217088.USD","MSTC","CONX","LU1571399168.USD","MSTX","SMST","LU0128525929.USD","LU0868494617.USD","HOOX","LU1267930813.SGD","MTYY","BK4532","LU1267930227.SGD","IE00BJT1NW94.SGD","FDIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665326953","title":"美股異動｜安進盤前跌5.4%，諾華同靶點藥物III期臨床失敗，Lp(a)賽道遭重創","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326953","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665326953?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:07","pubTimestamp":1788858422,"startTime":"0","endTime":"0","summary":"消息面上，诺华于9月4日公布，其与Ionis联合开发的降脂药物Pelacarsen，在名为LpHORIZON的III期临床试验中未能达到主要终点。诺华的Pelacarsen是全球首个针对Lp靶点进行心血管结局验证的III期药物。因此，市场担忧情绪蔓延到了同样在开发Lp药物的安进身上。多家分析机构认为，诺华的失败削弱了但并未完全推翻Lp这一靶点的可行性。安进后续公布的Olpasiran完整试验数据，将成为判断该靶点未来走向的关键。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260908/32363493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU0320765992.SGD","AMGN","LU0058720904.USD","LU2242652126.USD","IE00BJT1NW94.SGD","IE0002141913.USD","IBB","LU0289739699.SGD","BK4599","LU2089984988.USD","LU0208291251.USD","TBXU","IBBQ","BBH","PPH","BK4578","BK4588","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU0070302665.USD","LU0211331839.USD","BK4566","LU1571399168.USD","LU0320765489.SGD","LU1057294990.SGD","LU1061106388.HKD","SG9999001440.SGD","LU2112291526.USD","PJP","NVS","LU0109394709.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","BIB","BK4534","LU0122379950.USD","LU1023059063.AUD","BK4585","LU0868494617.USD","IE00B4R5TH58.HKD","BK4581","PBE","BK4532","LU2468319806.SGD","BK4139","BK4007","LU1983299246.USD","MEDX","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665258833","title":"安進股價盤前下跌5.4%；競爭對手諾華的膽固醇藥物後期臨床試驗失敗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665258833","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665258833?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 16:28","pubTimestamp":1788856084,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","IE00BJJMRZ35.SGD","AMGN","BK4566","LU0109394709.USD","LU1057294990.SGD","PPH","PSYK","LU2468319806.SGD","LU2112291526.USD","BK4581","IE00BJT1NW94.SGD","BIB","PJP","LU0889565916.HKD","IE0002141913.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","LU2242652126.USD","LU0320765992.SGD","BBH","LU0208291251.USD","BK4588","BK4533","BMED","LU1023059063.AUD","LU0058720904.USD","LU0868494617.USD","BK4532","IBBQ","LU2242646821.SGD","LU0289739699.SGD","IBB","LU1983299246.USD","BK4007","IBBJ","NVS","PBE","BK4578","LU1061106388.HKD","LU0320765489.SGD","MDTX","LU0070302665.USD","LU0211331839.USD","BK4534","BK4585","TBXU","SG9999001440.SGD","LU2089984988.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665349003","title":"富國銀行上調安進目標價至435美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665349003","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665349003?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 11:12","pubTimestamp":1788837128,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0889565916.HKD","LU0109394709.USD","AMGN","IE00B4R5TH58.HKD","LU0122379950.USD","LU1571399168.USD","PBE","LU2112291526.USD","BK4533","LU0058720904.USD","LU2468319806.SGD","UUP","LU2089984988.USD","PJP","BK4588","IBB","LU0320765992.SGD","LU1057294990.SGD","UDN","LU2242652126.USD","LU0289739699.SGD","LU0868494617.USD","LU1061106388.HKD","BK4582","BK4581","SG9999001440.SGD","TBXU","IE00BFTCPJ56.SGD","BK4566","LU1983299246.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","PGF","BK4139","LU2242646821.SGD","BBH","BIB","IBBQ","IE00B2B36J28.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4599","BK4534","BK4585","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665699390","title":"諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影","url":"https://stock-news.laohu8.com/highlight/detail?id=2665699390","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665699390?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768711,"startTime":"0","endTime":"0","summary":"罕见病药物备受期待市场关注点现将转向第四季度其RNA疗法del-desiran的后期临床试验结果。该药物用于治疗一种罕见肌肉疾病，系通过收购Avidity公司获得。诺华公司另一款抗炎药物雷米布替尼针对一种名为脓疱性汗腺炎的皮肤病所开展的研究数据，预计也将于今年公布。该药物上周在多发性硬化症患者的临床试验中取得了成功。这两家竞争对手的药物均在与佩拉卡森类似的临床试验中进行测试，这些试验依赖于确诊的心脏相关事件，且没有明确的结束日期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL4T44Z0IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491049909.HKD","LU1988902786.USD","MEDX","THNR","LLY","AGNG","IBB","WDNA","LLII","LU2324357040.USD","IXJ","FHLC","MHIP","BK4581","LU1551013425.SGD","IBBQ","ELIL","IYH","BK4588","LLYZ","BIB","PPH","OZEM","RXL","VHT","PBE","ELIS","AMGN","IHE","NAMS","TBXU","BBH","FTXH","LLYX","LU2746668974.SGD","MEDI","CURE","CANC","GDOC","XLV","LU0096364046.USD","IE00BK4W5L77.USD","TMED","TRUH","LU0456855351.SGD","PJP","JDOC","HRTS","SLN","ILDR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392789","title":"一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392789","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392789?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:15","pubTimestamp":1788765302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞士制药巨头诺华制药再遭临床试验打击——一周之内，该公司第二项重磅候选药物在后期研究中折戟。此次失利的是其潜在明星心脏病药物pelacarsen。受此消息影响，诺华在美上市股票上周五常规交易结束后一度下跌逾7%。开发类似心脏药物的安进股价上周五盘后也下挫近6%。诺华正寄望于一系列新药来支撑增长，以应对旗下多款重磅产品专利即将到期的压力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BIB","LU0058720904.USD","IE0009355771.USD","BK4533","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK4007","LU1057294990.SGD","MEDX","LU2242652126.USD","SG9999001440.SGD","BK4599","LU0070302665.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","LU0889565916.HKD","LU0211331839.USD","LU2089984988.USD","LU1061106388.HKD","AMGN","BK4532","BK4139","LU2242646821.SGD","BK4585","LU2112291526.USD","LU0320765489.SGD","TBXU","IE00B2B36J28.USD","LU0122379950.USD","BK4566","IE00B4R5TH58.HKD","LU1571399168.USD","LU2468319806.SGD","PBE","LU0320765992.SGD","IBBQ","BK4588","LU0289739699.SGD","LU0868494617.USD","NVS","PPH","PJP","LU1023059063.AUD","BK4581","IBB","BK4534","BK4578","IE0002141913.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664463098","title":"摩根大通投行聯席負責人：併購交易業務有望迎來創紀錄年份。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664463098","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664463098?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 02:58","pubTimestamp":1788375516,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEFN","IBBQ","VXF","IYH","DFMC","AAUM","PGF","GTPE","BK4582","RSPH","PEVC","MMID","TMED","PSP","TBXU","UYG","FFSM","BK4588","BK4585","PBPH","CANC","RFG","MNA","XLFI","ACTV","PRVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664194548","title":"安進（AMGN）罕見病藥物Tavneos將於27年3月1日被徹底撤銷英國上市許可","url":"https://stock-news.laohu8.com/highlight/detail?id=2664194548","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664194548?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:59","pubTimestamp":1788350357,"startTime":"0","endTime":"0","summary":"金吾财讯 | 英国药品监管机构MHRA宣布，暂停安进（AMGN）罕见病药物Avacopan Vifor（原商品名Tavneos）用于新患者，监管认定支撑该药物获批的关键临床试验数据已不可靠。该药2022年在英国获批，用于治疗两种罕见血管炎症自身免疫病。安进持有美国地区权益，由CSL集团（CSLLY）旗下CSLVifor负责英国等海外市场销售。新规9月1日落地，不再允许新患者启用该药物；为保障现有患者安全，设置6个月过渡用药期，2027年3月1日将彻底撤销其英国上市许可，现有患者可在此期间逐步更换替代治疗方案。安进方面公开表示不认可监管机构的决定，担忧该举措会对罕见病患者造成负面影响。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305627","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","AZNH","AMGN","IE00B4R5TH58.HKD","LU0122379950.USD","LU1571399168.USD","PBE","LU2112291526.USD","BK4533","LU0058720904.USD","LU2468319806.SGD","LU2089984988.USD","PJP","BK4588","IBB","LU0320765992.SGD","LU1057294990.SGD","LU2242652126.USD","LU0289739699.SGD","LU0868494617.USD","LU1061106388.HKD","BK4581","SG9999001440.SGD","TBXU","IE00BFTCPJ56.SGD","IPOS","BK4566","LU1983299246.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4139","LU2242646821.SGD","BBH","BIB","IBBQ","IE00B2B36J28.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4599","BK4534","BK4585","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891714","title":"高盛9月「確信名單」更新：美股納入福泰製藥(VRTX.US) 歐股力推萊茵、Adyen和塔蘭克斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891714","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891714?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:20","pubTimestamp":1788333621,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1144417596.USD","LU1868836591.USD","LU0432979614.USD","LU2237443549.SGD","BK4127","LU2324357040.USD","LU1674673691.USD","LU0868494617.USD","LU2471134952.CNY","BK4588","BBH","LU1868836914.USD","PBE","BIB","VXUS","TBXU","BK4585","LU0868494708.USD","IE0002141913.USD","LU0061475181.USD","LU1791807156.HKD","LU0289739699.SGD","IBB","LU0942090050.USD","SG9999001176.USD","LU0251131958.USD","IE00B19Z9P08.USD","VRTX","IE00BJJMRZ35.SGD","LU2462157665.USD","IBBQ","IE00B19Z9Z06.USD","LU2237438978.USD","LU2468319806.SGD","LU2456880835.USD","IE0009355771.USD","SG9999001176.SGD","LU2237443978.SGD","GSX","GNMX","IEV","VGK","LU1868837300.USD","LU0096364046.USD","LU2471134523.USD","IDNA","BK4550","BK4533","IE00BZ9MQY76.HKD","LU1668664300.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891705","title":"高盛9月「確信名單」更新：美股納入福泰製藥 歐股力推萊茵、Adyen和塔蘭克斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891705","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891705?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:20","pubTimestamp":1788333621,"startTime":"0","endTime":"0","summary":"进入秋季，高盛对其美国及欧洲市场的“确信名单”进行了更新，为投资者指明当前最看好的股票方向。本次调整中，美国名单新增一只大型生物科技股，欧洲名单则迎来三家新面孔。美国名单：新增福泰制药，移除盈透证券在美国市场，高盛将 $福泰制药$纳入确信名单，同时移除了 $盈透证券$，调整后名单保留23只股票。高盛还表示，塔兰克斯的国际零售业务是被低估的增长引擎。","market":"us","thumbnail":"https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490866.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0034235188.USD","XYZ","IBBQ","CRNX","BIB","LU0345770993.USD","LU2471134523.USD","GNMX","LU1868836757.USD","LU2236285917.USD","COP","IE00B19Z3581.USD","MSFX","UNHW","LU2362541273.HKD","XYZG","LU0106831901.USD","DAL","LU2456880835.USD","IBB","BK4504","GSX","LU2471134796.USD","UNHG","IBKR","IE00BFTCPJ56.SGD","BK4567","LU1868837136.USD","LU1868837300.USD","IE00B2B36J28.USD","LU2471134952.CNY","PBE","BK4533","LU0109394709.USD","SG9999001176.USD","LU2471134879.HKD","MSFU","EL","SG9999001176.SGD","BBH","LU2468319806.SGD","IE00BJT1NW94.SGD","MSFL","UN","MSFD","LU1585245621.USD","MSFY","IE0002270589.USD","MSFC","XYZY","MSFW","IE0004091025.USD","LU0889565916.HKD","VXUS","LU2265009873.SGD","VRTX","LU2417539215.USD","IE00BFXG1179.USD","BK4585","IEV","TBXU","LU2237443549.SGD","BK4532","VGK","MSFT","UNH","LU0432979614.USD","LU2750360641.GBP","IDNA","MSFO","UNHU","WFC","LU1069344957.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664347855","title":"英國監管機構因數據不可靠，暫停安進公司Tavneos用於新患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2664347855","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664347855?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:15","pubTimestamp":1788261324,"startTime":"0","endTime":"0","summary":"英国监管机构因数据不可靠，暂停安进公司Tavneos用于新患者路透9月1日-英国药品监管机构周二暂停了安进公司旗下AMGN.O研发的罕见病药物Tavneos对新患者的使用和销售，称支持该药获批的主要研究结果不可靠。监管机构表示，由于主要临床试验的数据不可靠，该研究已无法证明该药有效，也无法证明其益处大于风险。Tavneos由ChemoCentryx公司研发，安进公司于2022年以37亿美元收购了该公司。欧洲委员会于8月撤销了Tavneos的批准，此前监管机构发现其关键试验数据不可靠。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4T44T10B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","PBE","BK4566","IE00BJJMRZ35.SGD","LU2089984988.USD","BK7501","BBH","LU0122379950.USD","TBXU","LU1057294990.SGD","BK7511","BK4588","AMGN","BK7508","LU2468319806.SGD","SG9999001440.SGD","IBB","LU2242646821.SGD","LU2242652126.USD","LU0320765992.SGD","PJP","BK7067","BK4139","IE00B2B36J28.USD","LU0109394709.USD","IE0002141913.USD","LU2112291526.USD","CSL.AU","LU0889565916.HKD","BK4581","LU1983299246.USD","BK4533","BK4585","LU1061106388.HKD","LU1571399168.USD","IBBQ","LU0058720904.USD","LU0868494617.USD","BIB","BK4599","BK4534","LU1023059063.AUD","IE00B4R5TH58.HKD","IE0009355771.USD","LU0289739699.SGD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148791645","title":"英國藥品與健康產品管理局：通知上市許可持有方，自9月1日起暫停新患者使用、供應及銷售Avacopan Vifor","url":"https://stock-news.laohu8.com/highlight/detail?id=1148791645","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148791645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 17:35","pubTimestamp":1788255329,"startTime":"0","endTime":"0","summary":"英国药品与健康产品管理局（MHRA）已正式告知上市许可持有方，关于暂停Avacopan Vifor用于新患者的使用、供应及销售的相关决定。该措施自9月1日起生效。此番调整涉及该药物的市场流通环节，意在规范其临床应用范围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU2112291526.USD","LU0289739699.SGD","LU2089984988.USD","PBE","PJP","AMGN","BK4534","LU1061106388.HKD","BK4599","BIB","BK4533","LU0109394709.USD","LU0320765992.SGD","LU1057294990.SGD","LU1571399168.USD","BBH","TBXU","LU1023059063.AUD","LU0868494617.USD","LU0889565916.HKD","BK4588","IBB","LU2468319806.SGD","LU0122379950.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4139","IE00B2B36J28.USD","IE0009355771.USD","SG9999001440.SGD","BK4585","BK4566","BK4581","LU2242652126.USD","LU2242646821.SGD","IE0002141913.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664002674","title":"特朗普政府將宣佈藥品定價協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2664002674","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664002674?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 00:07","pubTimestamp":1788192474,"startTime":"0","endTime":"0","summary":"特朗普政府将宣布药品定价协议预计拜耳、武田、CSL以及中型生物技术公司将达成新协议路透此前曾报导，小型制药商认为参与其中的财务激励有限美国处方药价格往往是其他发达国家的近三倍路透8月31日-白宫一名官员表示，美国总统唐纳德·特朗普 预计将于周一宣布新一轮药品定价协议，这是旨在降低美国民众医疗保健成本举措的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4T44S1CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU0133085943.USD","LU2750360997.AUD","LU1712237335.SGD","LU2360106947.USD","IXJ","LU2602419157.SGD","LU0109391861.USD","SG9999002232.USD","LU0882574139.USD","LU2756315664.SGD","LU2112291526.USD","LU2237438978.USD","BK4516","LU0353189763.USD","LU1291159041.SGD","IE0004445015.USD","PJP","IE0005OL40V9.USD","LU2108987350.USD","LU2896262040.SGD","SG9999001440.SGD","IE00B19Z3B42.SGD","LU1983299246.USD","LU2471134796.USD","IE00BN29S564.USD","LU2471134523.USD","SG9999014898.SGD","BK4592","LU0456855351.SGD","LU2324357040.USD","SG9999015978.USD","LU1629891620.HKD","BK7511","MEDX","BIB","LU0321505439.SGD","LU1066051498.USD","LU1267930730.SGD","LU1366192091.USD","CURE","LU0114720955.EUR","IE00BK4W5M84.HKD","LU0708995401.HKD","GB00BDT5M118.USD","LU2461242641.AUD","LU2361044865.SGD","LU1232071149.USD","LU2471134879.HKD","IE0002270589.USD","IYH","LU2242652126.USD","LU1061106388.HKD","LU2468319806.SGD","LU2552382058.USD","BK7501","FTXH","SG9999014906.USD","CANC","LU1868837300.USD","LU2089984988.USD","BK4007","LU0079474960.USD","LU1623119135.USD","LU2236285917.USD","LU0640476718.USD","IE00B775H168.HKD","LU0158827781.USD","MHIP","IE00B7KXQ091.USD","IE000M9KFDE8.USD","LU0198837287.USD","LU2213496289.HKD","LU0225283273.USD","SG9999018857.SGD","SG9999003800.SGD","ELIL","TMED","IE00B3T34201.USD","LLY","LU2756315318.SGD","LU2028103732.USD","IE00BJT1NW94.SGD","ILDR","IE00BFSS7M15.SGD","LU2023250330.USD","LU1057294990.SGD","BK4533","LU0203202063.USD","SG9999015986.USD","LU0006306889.USD","LU0170899867.USD","LU0345770308.USD","LU0353189680.USD","LU0985481810.HKD","LU2552382132.HKD","LU1720051017.SGD","LU0823416689.USD","LU0868494617.USD","LU0432979614.USD","LU0210536198.USD","IE00BKPKM429.USD","LU1548497426.USD","LU2462157665.USD","SGXZ51526630.SGD","LU1023059063.AUD","LU0417517546.SGD","LU1988902786.USD","04332","LU0306806265.USD","LU2106854487.HKD","LU2750360641.GBP","LU2089283258.USD","LU0316494557.USD","LU2023250504.SGD","LU1804176565.USD","IHE","LU1868836591.USD","LU2237443382.USD","LU1093756168.USD","LU1814569148.SGD","LU0823434740.USD","BK4139","BK4550","LU0823434583.USD","LU2111349929.HKD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU0106261372.USD","AGNG","LU2211815571.USD","IE00BLSP4239.USD","LU2242646821.SGD","SG9999015952.SGD","LU1093756325.SGD","SG9999011175.SGD","IE00BJLML261.HKD","LU1035775433.USD","LU0471298694.HKD","LU0345770993.USD","LU2491050154.USD","LU0058720904.USD","PFE","IE00BJJMRX11.SGD","IE00B4R5TH58.HKD","LU2491049909.HKD","WDNA","LU2168564222.USD","HRTS","LU2417539215.USD","LU0266013472.USD","LU0323591593.USD","LU1064131342.USD","LU1883839398.USD","LU1145028129.USD","LU0889565916.HKD","LU2491050071.SGD","LU0096364046.USD","RXL","SGXZ31699556.SGD","LU0122379950.USD","LLII","LU2063271972.USD","IE0001KFT4U8.USD","LU0321505868.SGD","LU0354030438.USD","LU0354030511.USD","SG9999015945.SGD","SGXZ81514606.USD","LU0964807845.USD","IBBQ","LU0256863902.USD","LU2471134952.CNY","LU2746668974.SGD","PBE","CSL.AU","LU0238689110.USD","OZEM","LU2462591350.SGD","AMGN","LU0225771236.USD","LU0786609619.USD","LU2746668461.USD","IE00B2B36J28.USD","LU0306807586.USD","LU2271345857.HKD","LU0787776722.HKD","LU2357305700.SGD","LU1979441026.SGD","BK7508","TBXU","LU1069344957.HKD","LU1989771016.USD","IE00BWXC8680.SGD","LU2361044949.HKD","FHLC","SG9999002224.SGD","JDOC","LU2237443549.SGD","LLYX","LU0203201768.USD","LU0234572021.USD","MEDI","SG9999014880.SGD","LU2361045086.USD","BK4534","IE00BLSP4452.SGD","LU0109394709.USD","LU1551013342.USD","BK4585","IE00BKDWB100.SGD","SG9999017495.SGD","BK4581","LU0225284248.USD","SG9999001176.SGD","LU0672654240.SGD","LU1720051108.HKD","IE00B4JS1V06.HKD","LU2237443622.USD","LU2265009873.SGD","LU0320765059.SGD","LU1974910355.USD","LU0471298777.SGD","BK4566","IE0004445239.USD","LU1323610961.USD","LU2087625088.SGD","ELIS","LU2168564065.EUR","GDOC","IE0002141913.USD","PPH","LU2168563687.JPY","LU0256863811.USD","BK4599","LU1868836757.USD","LU1571399168.USD","LU2023251221.USD","LU1127390331.HKD","SGXZ99366536.SGD","VHT","IE0009355771.USD","LU0943347566.SGD","LU0097036916.USD","LU1066053197.SGD","LU2456880835.USD","IE00BK4W5L77.USD","LU2168564149.EUR","SG9999001176.USD","XLV","LU0683600562.USD","LU2264538146.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU2089284900.SGD","LU2552382215.SGD","LU1894683348.USD","SG9999014914.USD","IE00B19Z3581.USD","IE00B1XK9C88.USD","LU2596442595.SGD","BK7067","LU0094547139.USD","BK4568","LU1691799644.USD","LU1868837136.USD","IE00BFSS8Q28.SGD","IE00B1BXHZ80.USD","BK4588","LU0289739699.SGD","SG9999018865.SGD","TRUH","LU2237443895.HKD","LU0882574055.USD","LU0820562030.AUD","LU1280957306.USD","LU0820561818.USD","LU0158827948.USD","LU2237443978.SGD","IONS","LU0820561909.HKD","THNR","LU0689472784.USD","LU1894683264.USD","LU2237443465.HKD","LU0061475181.USD","LU0385154629.USD","LU2168564495.EUR","LU1551013425.SGD","LLYZ","LU0174119429.USD","LU1917777945.USD","SG9999013999.USD","LU0320765992.SGD","IE00BJJMRY28.SGD","IE00BFTCPJ56.SGD","LU0466842654.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663017770","title":"機構：爭奪天然氣資產推高併購交易規模創2013年以來新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017770","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017770?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 22:52","pubTimestamp":1788187964,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["DUG","RSPH","WTIU","KOLD","ACTV","UYG","VXF","FFSM","PRVT","IXC","PXJ","BK4570","IEO","IBBQ","TBXU","DFMC","CANC","PXE","IYH","BOIL","PSP","AAUM","FTXN","TMED","PEVC","DRLL","MNA","DIG","GTPE","DBC","ERX","RFG","GUSH","VDE","PBPH","IEFN","XOP","XES","XLFI","BK4585","FCG","USE","DBE","MMID","BK4588","DRIP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663778550","title":"安進（AMGN）降脂藥Repatha新臨床數據：可降低未發生心梗或中風高危患者20%死亡風險","url":"https://stock-news.laohu8.com/highlight/detail?id=2663778550","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663778550?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:48","pubTimestamp":1788173287,"startTime":"0","endTime":"0","summary":"研究结果显示，对于既往未发生过心肌梗死或中风的高危成年患者，在接受他汀类或其他降脂疗法的基础上加用Repatha，可显著降低20%的全因死亡风险，同时有效降低心血管死亡率。数据显示，Repatha能在治疗开启最早6个月内降低心梗风险，且将患者低密度脂蛋白胆固醇中位数降低至45mg/dL，远优于安慰剂组的109mg/dL。此外，欧盟委员会已于2026年8月批准扩大Repatha在欧洲的适应症，用于确诊或高危确诊的动脉粥样硬化性心血管疾病成年患者降低心血管风险。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/Mjk1NzA2YjQxMDg1MTQ0MjI1MzE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Mjk1NzA2YjQxMDg1MTQ0MjI1MzE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305491","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","BK4566","LU2242652126.USD","LU1057294990.SGD","LU0109394709.USD","LU0868494617.USD","BK4581","LU1061106388.HKD","BK4588","BBH","PBE","BK4139","BIB","LU2242646821.SGD","TBXU","BK4585","LU0058720904.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","SG9999001440.SGD","LU0320765992.SGD","LU0289739699.SGD","IBB","LU2089984988.USD","IE00BJJMRZ35.SGD","PJP","BK4599","IBBQ","LU1023059063.AUD","LU2468319806.SGD","IE0009355771.USD","LU0122379950.USD","LU1983299246.USD","BK4534","LU2112291526.USD","LU1571399168.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4533","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662091790","title":"南京諾令生物科技股份有限公司向港交所提交上市申請書，獨家保薦人為建銀國際。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662091790","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662091790?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 22:53","pubTimestamp":1787928801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS","BIOY","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662942093","title":"據港交所文件，維眸生物科技股份有限公司-B向港交所提交上市申請書。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662942093","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662942093?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 20:52","pubTimestamp":1787921537,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TBXU","IPOS","BIOY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":151,"code":"91000000","status":"200"}]}}